Explorez tous les épisodes du podcast The Lattice (Official 3DHEALS Podcast)
| Titre | Date | Durée | |
|---|---|---|---|
| Episode #130 | 3D Print Tiny Things with Adam Steege, Trio Labs | 13 Oct 2026 | 00:30:11 | |
The more minimally invasive medicine becomes, the smaller and more complex medical devices have to be. While that can mean better care and greater access for patients, it also creates a significant dilemma: how do you manufacture these devices at scale? Adam Steege, founder and CEO of Trio Labs, a Morrisville, North Carolina-based company, develops micron-scale metal parts for medical devices. He invented RIPL, or Resin Infused Powder Lithography, a lithography-based process that prints stainless-steel parts at five-micron resolution with tolerances as fine as 0.0005 inch and Ra32 surface finish, which are specifications normally associated with CNC machining. On The Lattice, Steege explains why Trio sells finished parts rather than 3D printers, how minimally invasive surgery and interventional cardiology push instruments smaller and more complex than machining or metal injection molding can economically produce, and why manufacturability is the third leg, alongside clinical need and design, of every successful device. Ultimately, Trio Labs aims to hit the sweet spot where complex, micron-scale designs lead the next generation of medical devices for patients. 00:00:00 - Welcome And A Parts-First Thesis
Subscribe to our premium version and support the show. Follow us: | |||
| Episode #129 | Additive Manufacturing Needs Policy To Reach Patients with Dr. Naomi Nathan | 01 Oct 2026 | 00:43:14 | |
Healthcare loves innovation right up until the bill shows up. We sit down with Dr. Nayumi Nathan (Naomi), a medical doctor turned public health and health economics leader, to unpack why medical 3D printing and additive manufacturing are often ready before the healthcare system is. If you’ve ever wondered why point-of-care 3D printing can thrive in one hospital and stall in another, the answer is usually not the printer. It is reimbursement, evidence, and policy. YouTube: coming soon Show notes: coming soon Subscribe to our premium version and support the show. Follow us: | |||
| Episode #128 | Biotools Can Beat Moonshots with Jim West | 27 Sep 2026 | 00:25:48 | |
Everyone wants to fund the next miracle drug. Jim West thinks differently. In this episode, the Associate Director of BioTools Innovator makes the case that life-science tools and diagnostics are the better risk-adjusted venture bet than many therapeutics: you trade the 100X biotech moonshot for a 5-to-10X return with better odds, little regulatory risk, and a roughly five-year horizon. He backs it with the accelerator's own numbers: 95% of the companies through its six cohorts are still operating or acquired, out of roughly 2,800 applications — and explains why focus (not technology) is what most tool founders get wrong, what strategic acquirers actually pay for, and why private equity and family offices are reshaping how these companies get funded. Subscribe to our premium version and support the show. Follow us: | |||
| Episode#127 | Lean Compliance For Medical 3D Printing With Erik Boelen | 17 Sep 2026 | 00:43:36 | |
We talk with Erik Boelen, founder of Qase3D, about how medical 3D printing went from a regulatory free-for-all to a world where hospital print labs function as medical device manufacturers. We break down MDR, CE marking, ISO 13485, and how to stay compliant with a lean system engineers will actually use. 00:00:00 - Welcome To The Regulatory Reality Show notes: https://3dheals.com/episode-127-lean-compliance-for-medical-3d-printing-with-erik-boelen/ YouTube: https://youtu.be/wR7TVN4WGno?si=pvQ-Fl7VJNgNRq7F Subscribe to our premium version and support the show. Follow us: | |||
| Episode#126| Biomaterials Frontier for Medical 3D Printing (Virtual Event Recording) | 14 Sep 2026 | 01:47:08 | |
The real frontier in medical 3D printing isn't the printer — it's the material. In this 3DHEALS panel, five researchers, founders, and industry leaders map the shift from printing structure to printing function, and from lab-stage novelty toward regulated, investment-grade material systems spanning soft bioresins, bioactive ceramics, and titanium lattices. Fabian Trumper (Arrakis Bio) argues that the best biomaterials are the ones our bodies already make, and explains how his team bio-manufactures True Human Collagen at industrial scale. Prof. Kamal Choudhary (Johns Hopkins) shows why AI is reshaping materials discovery — a "ChatGPT for materials scientists" — and why so much of the field still isn't reproducible. Dr. Andrew Weems (Resilient Medical) shares how a 3D-printed scaffold could finally modernize lumpectomy surgery for breast cancer patients. Ebrahim Yarali (MERLN, Maastricht University) reveals how geometry alone — architected "meta-biomaterials" and 4D printing — can steer stem cells toward bone or cartilage. And Dr. Scott Taylor (Poly-Med) breaks down absorbable polymers that dissolve into the body once healing is done. Moderated by Craig Rosenblum, President of Himed. In this episode:
Whether you're a researcher, founder, or investor, this is a fast, opinionated tour of where medical materials are heading next. 🎥 Watch the full session and explore more 3DHEALS events: https://3dheals.com/biomaterials-frontier/ 00:00:00 - Welcome And 3D Heals Missions Subscribe to our premium version and support the show. Follow us: | |||
| Episode 125| Inside Tech Transfer At UCLA From Patents To Patients | 03 Sep 2026 | 00:42:48 | |
A single university discovery can turn into a life-changing therapy, but only if someone can translate the science into a product, a company, and a development plan investors will actually fund. That is why we sat down with Mark from UCLA’s technology transfer and licensing team to demystify what happens after the lab result and before the biotech headline. We talk plainly about what a tech transfer office does, what it can license, and why “intellectual property” now stretches beyond patents into data, materials, and even carefully governed patient datasets. Show notes: coming soon YouTube: coming soon Subscribe to our premium version and support the show. Follow us: | |||
| Episode#123| Bioprinting In Microgravity with Dr. Michael Roberts ISS/CASIS | 20 Aug 2026 | 00:56:59 | |
Gravity shapes every lab workflow we take for granted, and it may be the hidden constraint behind some of the hardest problems in regenerative medicine. We sit down with Dr. Michael Roberts, a microecologist who led bioregenerative life support research at NASA’s Kennedy Space Center and now serves as Chief Scientific Officer of the International Space Station National Laboratory, to talk about what microgravity is actually good for and why biomanufacturing in space is no longer just sci-fi. Show notes: Pending Subscribe to our premium version and support the show. Follow us: | |||
| Episode #122| The Mini Brain That Learned Pac-Man: NAMs with Dr. Lowry Curley | 07 Aug 2026 | 00:49:33 | |
A brain organoid that can learn to play Pac-Man sounds like a stunt until you realize what it represents: measurable learning, rewiring, and human-relevant neural function that animal models often fail to predict. We talk with Dr. Lowry Curley, founder of Luna LifeSci and former CEO and co-founder of Axosim (now 28 Bio), about why neuroscience drug development breaks so often and how NAMs are finally giving teams better tools to make safer calls earlier. Show notes: https://3dheals.com/episode-122-new-approach-methodologies-nams-with-dr-lowry-curley/ YouTube: https://youtu.be/suVxiYZgPVE Subscribe to our premium version and support the show. Follow us: | |||
| Episode #121| Absorbable Biomaterials with Dr. Rao Bezwada | 30 Jul 2026 | 00:51:40 | |
Absorbable biomaterials have transformed modern medicine, enabling implants, sutures, and drug-delivery systems that safely degrade once their function is complete. Dr. Rao S. Bezwada has helped shape the field of bioresorbable polymers for more than three decades. As the inventor of Monocryl®, the absorbable suture that has generated more than $2 billion in worldwide sales, and the holder of more than 150 U.S. patents, his innovations have influenced everything from surgical sutures to next-generation biomaterials. In this episode of The Lattice, Dr. Bezwada joins Dr. Jenny Chen to discuss the science behind bioresorbable polymers, the chemistry that controls how materials degrade, and what the next generation of resorbable biomaterials could make possible. ⚠️ Disclaimer: YouTube video: Show notes: https://3dheals.com/episode-121-absorbable-biomaterials-with-dr-rao-bezwada/ Subscribe to our premium version and support the show. Follow us: | |||
| Episode #119 | 3D Printing At The Dentist with Dr. Nabeel Cajee | 16 Jul 2026 | 00:49:55 | |
If you have ever wondered why dentistry can feel both high-tech and oddly hand-built at the same time, this conversation connects the dots. We talk with Dr. Nabeel Cajee, an oral implantologist in Newport Beach and faculty at Torque Academy and Implant Ninja School, about what it really takes to bring digital dentistry into daily patient care without turning your practice into a science project. From the earliest days of open-source 3D printing to today’s clinical workflows, he breaks the ecosystem down into what actually matters: data capture, dental CAD design, and fabrication with dependable post-processing. Show notes: https://3dheals.com/episode-119-where-is-dental-3d-printing-with-dr-nabeel-cajee/ YouTube Video: https://youtu.be/FOKQNpMJjb4?si=DImMXMXEiNH5oheH Subscribe to our premium version and support the show. Follow us: | |||
| Episode#117| Monica Wellejus:The Road to 3D-Printed Bone | 21 Jun 2026 | 00:43:57 | |
Ossiform is on track to bring the first 3D printed resorbable bone implant to the US market. The company’s preclinical data showed full bone regeneration in six months. Monica Wellejus, Chief Commercial Officer of Ossiform, joins The Lattice to explain how a company built to personalize bone implants for craniomaxillofacial surgeries is pivoting to mass-produced bone implants for foot deformity, and why hospital finance teams, not just the surgeons, may decide whether this technology actually reaches patients. Subscribe to our premium version and support the show. Follow us: | |||
| Episode #115| Professor Paul Dalton: Inventing Melt Electrowriting and the Future of Biofabricationrication | 04 Jun 2026 | 00:58:39 | |
What does it take to invent a technology that didn't exist before? In this episode, host Dr. Jenny Chen sits down with Professor Paul Dalton, the inventor of melt electrowriting (MEW) and one of the rare "triple threats" in science: an inventor, educator, and futurist. This is also a conversation about science, creativity, and why MEW isn't just a technology but a movement. Paul takes us from a boredom-filled childhood on a rural farm outside Perth, Australia, to the ophthalmic research lab where he helped build artificial corneas that restored sight to blind patients. He shares the moment a failing electrospinning experiment pushed him toward MEW instead — and the "breathless" discovery under the microscope that became MEW. Along the way, Jenny and Paul explore:
Plus, a remarkable offer for listeners at the end of this episode. YouTube recording: Coming soon Subscribe to our premium version and support the show. Follow us: | |||
| Episode #114| Interview With Brigitte de Vet-Veithen, CEO of Materialise | 11 May 2026 | 00:41:41 | |
This is our second episode recorded at the Materialise conference. Our guest for this episode is no other than the CEO of Materialise Brigitte de Vet-Veithen. It is a pleasure for me to be able to conduct this interview, because Materialise is such a legendary company that has spent 35 years building the software and services infrastructure behind patient-specific implants, surgical planning, and point-of-care manufacturing. We also got to know Brigitte as a person and the new leader of the company. Importantly, we covered the metrics that signal adoption, challenges to scale beyond the halo case, and her vision for the industry. In my opinion, this is perhaps one of the most important conversations for the medical 3D printing industry in 2026. Highlights of this episode: • Brigitte's journey from MedTech leadership to being the CEO at Materialise Show Notes: https://3dheals.com/episode-114-interview-with-brigitte-de-vet-veithen-ceo-of-materialise/ YouTube: https://youtu.be/9PgME2RAmog?si=t-0X_DkrBdRg4MHe Subscribe to our premium version and support the show. Follow us: | |||
| Episode#113| How 3D Printing Explains the Unexplainable in Congenital Heart Disease with Dr. Tristan Ramcharan | 10 May 2026 | 00:16:02 | |
This is one of two episodes we have recorded during our trip to Leuven Belgium for the Materialise 2026 Conference, focusing on 3D planning and 3D printing in hospitals. We talked with Dr. Tristan Remcharan about how pediatric cardiology imaging can become something you can literally hold, using 3D segmentation and 3D printing to make congenital heart disease easier to plan, teach, and explain. We also dig into the 2D versus 3D generational divide and the real-world funding hurdles that decide whether point-of-care 3D becomes routine care. Show notes: https://3dheals.com/episode-113-how-3d-printing-explains-the-unexplainable-with-dr-tristan-ramcharan/ YouTube Video: https://youtu.be/eNUQWwJq5HM?si=3QhxXxvvUaEhO1MD The 3D cardiac printing program at Birmingham Children's Hospital is funded by charitable donations. To support Tristan's works directly: Birmingham Children's Hospital Charity — https://www.bch.org.uk/appeal/donate Donate to the 3D cardiac printing program Subscribe to our premium version and support the show. Follow us: | |||
| Episode# 112 | Automating Compounding Pharmacies: Prof. Alvaro Goyanes, FabRx | 23 Apr 2026 | 00:15:33 | |
You can learn a lot about the future of healthcare by watching how a single pill gets made. From a small office in London, we sit down with Prof Alvaro Goyanes, co-founder and CEO of FabRx, to unpack how 3D printed pharmaceuticals are turning personalized medicine from an idea into a working system. If you’ve ever wondered why patients still get forced into a handful of standard doses, this conversation shows what changes when medicine becomes software-driven and printable on demand. About Our Guest:
Show notes: Coming soon YouTube: Coming soon Subscribe to our premium version and support the show. Follow us: | |||
| Episode #110 | Neurotech Investing With Varun Turlapati, Chaanakya Capital | 10 Apr 2026 | 01:02:03 | |
Neurotech is the category most investors whisper about and then walk away from: too technical, too regulated, too slow. We wanted to talk to someone who leans in anyway, so I sat down with Varun Turlapati, founder of Chanakya Capital, to hear how he’s building an early-stage fund dedicated to neurotech devices and why he thinks the “long horizon” objection often misses what’s actually happening on the ground. Show notes: https://3dheals.com/episode-110-neurotech-investing-with-varun-turlapati-chaanakya-capital/ YouTube recording: coming soon Subscribe to our premium version and support the show. Follow us: | |||
| Episode #109| March Newsletter: From Bioprinted Organs To FDA Cleared Implants In Healthcare 3D Printing | 29 Mar 2026 | 00:11:01 | |
We track the biggest healthcare 3D printing stories from March 2026, from bioprinted organs and sustainable bioinks to FDA-cleared implants and hospital point-of-care wins. We also look at how 3D printed cancer tools, training models, microrobots, and AI quality control are moving from research into real clinical and manufacturing workflows. Complete show notes, including links to all articles mentioned in this podcast, are here. Subscribe to our premium version and support the show. Follow us: | |||
| Episode #108 | Teleporting Medicine with 3D Printing - Dr. Stephen Ryan, PolyUnity | 14 Mar 2026 | 00:55:58 | |
What happens when a hospital needs a simple part but the supply chain takes weeks or months to deliver it? Dr. Stephan Ryan, physician and co-founder of PolyUnity, set out to solve that problem by helping hospitals produce parts themselves through safe, compliant 3D printing. In this episode, Stephen Ryan shares how early clinical experiences and an academic 3D printing lab evolved into a platform designed to help hospitals manufacture equipment on demand. The COVID pandemic accelerated that vision, exposing major supply chain gaps and pushing the team to rapidly scale production. Stephen Ryan explains how those lessons shaped PolyUnity’s approach to building practical additive manufacturing systems within the realities of healthcare procurement, regulation, and hospital workflows. Full video interview: https://youtu.be/cO7mTr5GLJ8?si=icmU03OI1cPDZJL9 About our guest: Dr. Stephen Ryan is a physician, entrepreneur, and the co-founder and Chief Medical Officer of PolyUnity, a Canadian health tech company focused on lowering the barrier for hospitals to adopt 3D printing through its i3D platform and solutions. His work centers on building software, quality systems, and distributed print capacity so that hospitals can reliably order and receive end use 3D printed parts, from simple fixtures to clinically relevant devices, within existing procurement and regulatory frameworks. Subscribe to our premium version and support the show. Follow us: | |||
| Episode#107 | The Lattice Feb 2026 - Latest News in Healthcare 3D Printing | 23 Feb 2026 | 00:06:50 | |
We map the biggest shifts in healthcare 3D printing this month, from emissions safety to custom eyewear, implant surfaces, microfluidics, and space-based biomanufacturing. We weigh promise against risk and share where standards and design can close the gap. See blog post related to this podcast: https://3dheals.com/the-lattice-feb-2026-advanced-devices-custom-eyewear-and-hidden-health-risks-of-3d-printing/ Subscribe to our premium version and support the show. Follow us: | |||
| Episode #106| Bionic Hands For Humans and Robots: The Psyonic Story | 22 Feb 2026 | 00:53:51 | |
We share how a decade of soft robotics, open APIs, and relentless iteration turned a 3D-printed prototype into a durable, touch-sensing bionic hand used by amputees and robots. Stories of failure, funding, and firsts reveal how speed, sensation, and design choices translate to real lives and real factories. Show notes: https://3dheals.com/aadeel-akhtar-bionic-hands-for-humans-and-robots-the-psyonic-story/ YouTube: https://youtu.be/mDVMRhjXr0w?si=qoZrScjaC6nbiPMJ About our guest: Dr. Aadeel Akhtar, CEO of PSYONIC, founded the company to create advanced, accessible bionic limbs after meeting a young girl in Pakistan who was missing a limb. PSYONIC's bionic Ability Hand is the fastest on the market, impact-resistant, and the first to provide a sense of touch. It is also covered by Medicare and is being used by humans and robotics companies globally, including NASA, Meta, Mercedes, and Google. Dr. Akhtar earned a Ph.D. in Neuroscience and an M.S. in Electrical & Computer Engineering from the University of Illinois, along with a B.S. in Biology and an M.S. in Computer Science from Loyola University Chicago. He’s been recognized by MIT Technology Review and Newsweek and secured a 3-shark deal on Shark Tank. Subscribe to our premium version and support the show. Follow us: | |||
| Episode #105 | Jan 2026 News: ARPA-H Organ "Moonshots", Point-of-Care Manufacturing, and More | 26 Jan 2026 | 00:05:13 | |
We track a month of fast-moving news in healthcare 3D printing, from organ-scale bioprinting programs and ARPA-H’s funding model to point-of-care tools already entering clinics. The throughline is clear: vascularization, immune compatibility, and scale are converging with real-world deployment. Shownotes: https://3dheals.com/lattice-news-arpa-h-organ-moonshots-point-of-care-manufacturing-and-more/ Subscribe to our premium version and support the show. Follow us: | |||
| Episode #102 | Can Bioprinting Reshape The Future of Immunology? | 19 Dec 2025 | 00:41:34 | |
We explore how to move IVIG from donor scarcity to on‑demand manufacturing with tissue‑engineered bioreactors, and why that shift could lower costs, expand access, and improve consistency. We dig into polyclonal advantages, regulatory guardrails, scaling plans, and what success would mean for complex biologics beyond antibodies. Show notes: https://3dheals.com/episode-102-can-bioprinting-bioreactor-reshape-the-future-of-immunology/ About our guests: Dr. Melanie Matheu is an immunologist, inventor, and biotechnologist recognized for pioneering work in high-resolution tissue engineering and human immunology. She received her PhD in Physiology and Biophysics with a focus on Immunology from UC Irvine and completed postdoctoral training at VIB (Ghent University, Belgium) and UC San Francisco, where she specialized in 2-photon imaging and cellular immune responses. As founder of Prellis Biologics, Dr. Matheu brought forward laser-based tissue bioprinting to solve complex challenges in organ transplantation and therapeutic antibody discovery. She later co-founded Lyric Bio, where she serves as Chief Scientific Officer, advancing scalable biomanufacturing platforms and rapid human immune system modeling. Dr. Matheu has authored numerous peer-reviewed publications, holds multiple patents, and is a passionate advocate for innovation at the intersection of immunology and bioengineering. Kevin Shannon (Kayj) holds a degree in Molecular Biology from Princeton University and a MBA from Stanford Graduate School of Business. Kayj has held positions spanning the biotech ecosystem including start-ups, big pharma, venture capital, and consulting. As part of Corporate Strategy at Amgen, he worked with Amgen’s C-Suite to shape long-term strategy, built partnerships in novel therapeutic modalities, and led investments in emerging categories including cell & gene therapy, antibody engineering, single cell analysis, and quantum computing. Kayj has also consulted for multiple VC funds where he developed investment theses and performed diligence in emerging technologies. Most recently, led business development for Zafrens, raising >$20M and securing two pharma company partnerships. Subscribe to our premium version and support the show. Follow us: | |||
| Episode #101 | Therapeutic Hardware: Can Implants Also Heal? With Alyssa Huffman Allumin8 | 27 Nov 2025 | 01:08:04 | |
In this episode, Alyssa Huffman, CEO and co-founder of Allumin8, shares the six-year journey behind a first-of-its-kind 5.5 mm porous, 3D-printed pedicle screw. We discussed how Allumin8 earned FDA clearance and why design details matter for fatigue, fixation, and fewer revisions. We also map a path toward therapeutic hardware that integrates orthobiologics without slowing surgeons down. Critical questions addressed: Why does 5.5 mm matter so much? How does Gaussian topography support bone ingrowth?
Stay tuned for our show notes for relevant links, video highlights, glossary of terms, and more resources to enjoy this episode. Subscribe to our premium version and support the show. Follow us: | |||
| Episode #98 | Meeting the Bioprinting Vascular Challenge: VoxCell CEO Dr. Karolina Valente | 04 Nov 2025 | 01:04:36 | |
In this episode, Dr. Karolina Valente, Founder and CEO of VoxCell BioInnovation, discusses her journey in biotechnology, focusing on 3D bioprinting and its impact on cancer research and drug discovery. She shares insights into her leadership at VoxCell, the company's growth, and the accolades it has received. Dr. Valente also talks about the importance of partnerships, the future of biotechnology, and her personal experiences that drive her passion for innovation. Questions answered:
See full show notes, links, and resources. Subscribe to our premium version and support the show. Follow us: | |||
| Episode # 97 | Is ChatGPT Making Us Dumb? | 01 Nov 2025 | 00:11:47 | |
Summary
Show Notes: https://3dheals.com/is-chatgtp-or-ai-making-us-stupid-two-cents/
Subscribe to our premium version and support the show. Follow us: | |||
| Episode #96 | The Future of Surgical Digital Twin with Gilly Yildirim (CEO, Vent Creativity) | 30 Oct 2025 | 01:13:44 | |
How well do we really understand the body? For decades, surgeons have relied on static scans and flat 2D models to plan procedures. Gilly Yildirim believes it’s time to expand our view to more dimensions. As founder and CEO of Vent Creativity, he is bringing together point clouds, digital twins, and physics-based AI to capture movement with a level of precision that static imaging is far from. Yildirim shares the thinking that shaped his company’s approach. The team’s goal wasn’t to design a product, but to build a service that integrates into real clinical practice. Vent’s technology includes Minerva, an adaptive AI engine trained on real anatomical data. It powers Hermes, an FDA-cleared knee planning tool, and inVENT, a cloud platform that lets surgeons explore patient-specific digital twins in full 3D. Subscribe to our premium version and support the show. Follow us: | |||
| Episode #95 | Microfluidics & Additive Innovation with Paul Marshall | 26 Sep 2025 | 01:01:08 | |
Microfluidics has long promised to reshape diagnostics, drug discovery, and laboratory science. Microfluidics is about manipulating how tiny amounts of liquid move through channels no wider than a human hair; a "lab on a chip" diagnostic. Now imagine being able to 3D print those channels instead of painstakingly etching them. Paul Marshall, CEO of Rapid Fluidics, is working to improve the norm by applying additive manufacturing to the design and production of microfluidic systems. In this episode, Jenny Chen speaks with Marshall about how 3D printing enables fluidic devices with architectures that cannot be produced through conventional techniques. Traditional fabrication locks researchers into rigid patterns and flat geometries. Paul's work extends beyond basic microfluidics. His team creates remarkably detailed anatomical models by converting medical imaging data into functional vascular systems that mimic human biology. These models provide alternatives to animal testing and training platforms for medical procedures. They've also worked on embedding electronics directly into microfluidic devices, creating "smart" systems that can measure biological changes in real-time. Their work clearly demonstrates the potential of infusing engineering precision with scientific imagination. Paul Marshall reflects on the growth of his career as a founder by detailing the progression from experimental prototypes to a growing enterprise serving research communities. Marshall launched this venture at the beginning of the COVID-19 pandemic, a seemingly unpromising time to start a business. However, as diagnostic companies pivoted to develop coronavirus tests, the demand for rapid prototyping exploded. Now five years later, Rapid Fluidics serves global healthcare giants from their base in Newcastle, England, while planning expansion to the United States. This conversation offers a perspective on microfluidics that goes beyond the traditional. If you’ve ever wondered how big breakthroughs emerge from small scales, this episode makes the case that the tiniest channels can carry some of the most exciting ideas. Subscribe to our premium version and support the show. Follow us: | |||
| Episode #93 | 3D Design & Geometric Intelligence with Elissa Ross | 12 Sep 2025 | 01:02:34 | |
What happens when advanced mathematics meets manufacturing? The result is a new way of creating products that range from record-breaking running shoes to life-changing medical devices. In this episode, we sit down with Elissa Ross, mathematician and CEO of Metafold 3D, to explore how her company is using mathematics to reshape design and manufacturing. Metafold’s platform is built on geometric intelligence which is her company's novel approach that transforms shapes into data that can be analyzed and improved. Instead of simply representing objects the way traditional CAD software does this method allows engineers to simulate and optimize designs with greater speed and accuracy. At the core of this approach is implicit modeling with signed distance functions. While it may sound highly abstract, it has very practical applications. This technique allows manufacturers can run thousands of simulations in the time it would normally take to analyze a single design. The result is shorter development cycles and products that perform better in the real world. Ross also reflects on her journey building Metafold, from its early focus on 3D printing to its current role serving major industries. She explains how their API-first platform gives customers the flexibility to solve specific challenges, such as analyzing tolerances, reusing similar parts, or predicting how designs will hold up under different conditions. Whether you are a designer, an engineer, or simply curious about how mathematics is shaping the technologies around us, this episode offers a thoughtful look at the future of manufacturing intelligence. Shownotes: Check back soon Podcast Engineer: Faith Fernandes Subscribe to our premium version and support the show. Follow us: | |||
| Episode #92 | Nanochon: Joint Repair Layer by Layer | 27 Aug 2025 | 01:09:48 | |
Cartilage injuries sideline millions every year, yet current treatments often fail to restore long-term function. In this episode, Dr. Nathan Castro and Dr. Ben Holmes, co-founders of Nanochon, explain how they are tackling this challenge with a 3D-printed implant designed not only to replace damaged tissue but to help it regrow. What began as a collaboration in a graduate lab has grown into a company now preparing for its first human clinical trial. Their journey began at George Washington University in Dr. Grace Zhong’s tissue engineering lab, where the freedom to explore outside of strict grant-funded projects encouraged bold experimentation. Nathan even purchased specialized materials with his own money to expedite early tests. That investment in curiosity became the foundation for a technology that could change how orthopedic surgeons treat cartilage damage. Nanochon’s implant blends strength with biology. It pairs a smooth articular surface with a porous lattice that integrates directly with surrounding tissue. Traditional approaches, Nathan explains, can be “like filling a pothole with jelly.” By contrast, their device provides stability without the need for sutures or pins. Despite being less than half the thickness of conventional implants, it requires two to three times more force to dislodge, which may result in shorter recovery times for patients. From there, the company advanced step by step. They began with small animal studies in rats, progressed to goats, and finally proved the implant’s strength and integration in horses. These results not only built regulatory confidence but also convinced investors. With Health Canada’s approval for its first-in-human trial, Nanochon stands on the edge of translating a decade of persistence into clinical impact. Ben and Nathan also reveal the realities of building a medical device startup, including raising funds during tight markets, meeting ISO 13485 quality standards, and learning to manage external contractors. This conversation is a rare look behind the curtain of medtech entrepreneurship. It shows how innovation happens in steady layers, built one on top of another, much like 3D printing itself. Podcast Engineer: Faith Fernandes Subscribe to our premium version and support the show. Follow us: | |||
| Episode #90 | 3D Printing Across Decades with Lee Dockstader | 14 Aug 2025 | 01:05:56 | |
Lee Dockstader takes us on a fascinating journey through the commercialization of 3D printing in healthcare, drawing from his decades of experience with industry giants like HP and 3D Systems. Dockstader is one of the major pioneers of the 3D printing revolution that helped transform medical applications today. As he looks back on his career, Lee Dockstader leaves listeners with a clear message. Persistence pays off, and finding the right champions within an industry can be the key to turning groundbreaking ideas into world-changing realities. Stay tuned for show notes with relevant links and resources. Sound Engineer: Faith Fernandes Subscribe to our premium version and support the show. Follow us: | |||
| Episode #88 | Shaping Veterinary Medicine in 3D with Dr. Bill Oxley | 17 Jul 2025 | 00:59:19 | |
What happens when cutting-edge technology meets veterinary expertise? Precision, innovation, and better outcomes for our four-legged family members. Dr. Bill Oxley, a prominent figure in veterinary orthopaedics, walks us through the evolving world of 3D-guided veterinary surgery. With years of surgical experience behind him, Dr. Oxley began to question the limits of traditional planning methods. Complex bone deformities that looked manageable on initially often became challenges in the operating room. The tools weren’t the problem. The planning was. His solution? Bringing veterinary orthopedics into the three-dimensional world through advanced imaging, computer-aided design, and 3D printing. Show notes, photo gallery, resource links: Please see our show notes here. Sound Engineer: Faith Fernandes Subscribe to our premium version and support the show. Follow us: | |||
| Episode #87 | Lattice News Summary: The Bioprinting Revolution & More | 10 Jul 2025 | 00:23:49 | |
This is an AI-generated audio version of the news section of the Lattice Newsletter. You can find the full newsletter, including a list of recent healthcare 3D printing and bioprinting news here. Full Lattice Newsletter Archive. Highlighted news this week:
Subscribe to our premium version and support the show. Follow us: | |||
| Episode #86 | AI's Vital Role in Medical 3D Printing (Virtual Event Recording) | 29 Jun 2025 | 01:48:39 | |
Artificial intelligence is transforming medical 3D printing and bioprinting. In this virtual event, hear from a panel of experts from across the globe. Our speakers showcase the practical applications of AI in creating personalized medical solutions that were previously impossible. At the National University of Singapore, Dr. Gopu Sriram explores dental applications of 3D bioprinting. He discusses how an AI-optimized bioprinting process allow for the biofabrication of personalized gum tissue constructs. Gum disease is a worldwide public health burden that affects almost half adults over age thirty. This solution not only addresses these patients, but dramatically accelerates experimental timelines. Focusing on women's health, Aye Nyein San from Cosm Medical shared how their AI-powered digital gynecologic devices are giving women their lives back, with patients describing their products as "magical" and "life-changing." Shownotes: https://3dheals.com/event-recap-artificial-intelligence-updates-for-3d-printing-and-bioprinting/ Podcast Engineer: Faith Fernandes Subscribe to our premium version and support the show. Follow us: | |||
| Episode #85 | Jetting the Impossible: Ben Hartkopp on Printing Ultra-Viscous Materials | 01 Jun 2025 | 00:22:54 | |
Printhead technology may not sound revolutionary, but what if it could radically transform the way we manufacture everything from electric motors to medical implants? That's exactly what Ben Harkoff and his team at Quantica have achieved with their breakthrough inkjet system that can handle materials 10-20 times more viscous than any conventional technology. Complete show notes with references Subscribe to our premium version and support the show. Follow us: | |||
| Episode #84 | Tuan Tranpham On 3D Printing Mega-Trends | 08 May 2025 | 00:58:55 | |
Tuan Tranpham shares his extraordinary journey from Vietnamese refugee to 3D printing industry leader, offering unique insights on industry evolution, technological innovation, and future trends. His global perspective bridges Eastern and Western manufacturing approaches while highlighting continuous carbon fiber printing opportunities and microfactory development.
Subscribe to our premium version and support the show. Follow us: | |||
| Episode #83 | Ceramics, Conferences, and the Future of 3D Printing With Craig Rosenblum | 02 May 2025 | 00:49:31 | |
When EOS president Glynn Fletcher declared "3D printing is cool, but cool is not a business model" at Rapid TCT 2025, he captured the evolution across the additive manufacturing landscape. In this eye-opening conversation with Craig Rosenblum, president of Himed, we explore how the industry matures beyond technological demonstrations toward practical, sustainable applications. Subscribe to our premium version and support the show. Follow us: | |||
| Episode #81 | From J&J to the Future: Sam Onukuri's 30-Year Adventure in 3D Printed Medical Devices | 19 Apr 2025 | 01:20:55 | |
Sam Onukuri takes us through his remarkable 30-year journey at Johnson & Johnson, where he transformed the landscape of medical devices through pioneering work in 3D printing technology. As a material scientist who led the development of J&J's Center of Excellence for additive manufacturing, Sam offers rare insights into how a global healthcare giant approached innovation and personalized medicine. Subscribe to our premium version and support the show. Follow us: | |||
| Episode #80 | Live from San Francisco: Innovation in 3D Printing & Bioprinting | 13 Apr 2025 | 01:29:57 | |
3DHEALS kicked off its first in-person/hybrid event in 2025 in San Francisco, welcoming investors, entrepreneurs, and innovators in the space. The healthcare industry is transforming, driven by 3D printing and bioprinting technologies redefining patient care. This exclusive in-person hybrid event offered an opportunity to explore the latest advancements in custom prosthetics, implants, bioprinted tissues, and scaffolds. The remarkable convergence of 3D printing and healthcare transforms medicine through customized solutions that weren't possible a decade ago. This episode brings together five leaders in the healthcare field who are harnessing additive manufacturing to solve real clinical problems and improve patient outcomes. Summary:
The experts emphasize that successful innovation must be evidence-based, addressing validated clinical problems rather than pursuing complexity for its own sake. The speakers agreed, "Just because it's complex doesn't mean it's better." This wisdom encapsulates the mindful approach needed as we continue exploring the vast potential of 3D printing in healthcare. SUBSCRIBE to join us at future 3DHEALS conferences to connect with innovators and investors in the rapidly evolving field of 3D printing for healthcare applications. Watch this event recording on demand. Check out our blog for an in-depth analysis of the event! Youtube Event Highlight Playlist. Subscribe to our premium version and support the show. Follow us: | |||
| Episode #79 | The Orthopedic Pulse: AAOS 2025 With Matthew Henshaw | 27 Mar 2025 | 01:08:24 | |
Jenny and Matthew discussed the latest trends and innovations in the orthopedic and medical device industry, including regenerative medicine approaches for joint and spine conditions, new technologies like 3D printing and wireless endoscopes, and workflow management solutions to improve hospital efficiency after Matthew's recent blog about his AAOS 2025 experiences. They highlighted exciting startups like Genix, Osteal Therapeutics, and Ospitek that are disrupting traditional treatment paradigms. Matthew also shared his insights on the changing landscape of industry conferences and the potential impact of politics and regulation on medical innovation. Overall, the conversation covered a wide range of cutting-edge developments that could significantly improve patient outcomes and transform the future of orthopedics. Introductions and background Jenny and Matthew introduce themselves and provide background on their respective roles and businesses. Trends at recent industry conferences Matthew shares his observations from attending recent industry conferences like the Canaccord Genuity and AAOS events. He notes trends around decreasing surgeon attendance at the larger conferences, and increased interest in regenerative medicine and solutions for prosthetic joint infections (PJI). Regenerative medicine innovations Matthew highlights two promising regenerative medicine companies - DiscGenics, Osteal Therapeutics, which has an implantable pain relief solution. He discusses the potential for these innovations to disrupt traditional spine surgery Advancements in surgical tools and workflow Matthew discusses new technologies like wireless endoscopes from companies like Lazurite and single-use endoscopes from Pristine Surgical that are improving surgical visualization and sterility. He also highlights Ospitek, a company using real-time patient tracking to optimize hospital workflow and efficiency. Potential impact of political changes Matthew shares his perspective on how the new Trump administration may impact medical device companies. Recap and future outlook Jenny and Matthew conclude by discussing the dynamic and evolving nature of the medtech industry, and the importance of remaining optimistic about the potential for innovation to improve patient outcomes, despite political and economic uncertainties. Subscribe to our premium version and support the show. Follow us: | |||
| Episode #77 | Orthopedics Meets 3D Printing: A Journey Into the Future | 27 Feb 2025 | 02:05:29 | |
We examine the pivotal role of 3D printing technology in reshaping orthopedic implants and enhancing patient outcomes in this virtual event. This discussion navigates the crossroads of innovation and caregiving in modern medicine by featuring expert insights from industry leaders. Full on-demand recording: https://3dheals.com/courses/3d-printed-devices-in-orthopedics/ Subscribe to our premium version and support the show. Follow us: | |||
| Episode #76 | Treating Type I Diabetes with FRESH Bioprinting: Interview with Mike Graffeo | 15 Jan 2025 | 00:42:13 | |
Discover FRESH 3D bioprinting with Mike Graffio, CEO and co-founder of Fluoform3D. Having met at Carnegie Mellon University, Mike and Adam Feinberg have been on a mission to revolutionize the field of bioprinting, focusing on creating replacement tissues and organs without introducing foreign substances into the body. Mike shares the captivating journey from their engineering days in the 1990s through a pivotal 2015 conversation that transformed their research into a thriving startup and onto achieving significant milestones like developing living cardiac tissues and heart valves by 2018. Subscribe to our premium version and support the show. Follow us: | |||
| Episode #75 | #VentureCapital #Investor panel discussion for #3dprinting #startups #pitch3D #demoday | 13 Jan 2025 | 01:02:23 | |
Our panel of investors at the 3DHEALS Pitch3D Demo Day 2025 provide 3D printing startups and entrepreneurs advice and opportunities as they start their journey in MedTech. Subscribe to our premium version and support the show. Follow us: | |||
| Episode #68 | Interview Dr. Mohit Chhaya: BellaSeno | 18 Aug 2024 | 01:10:19 | |
This just dropped! #podcast This past Saturday, I had a pleasant visit from Dr. Mohit Chhaya, CEO and co-founder of BellaSeno, a startup in Leipzig, Germany, working on #3Dprintedimplants for soft tissues and bone. We had some nice green tea and pastries and chatted about many things from his worldly experiences of residing in four countries and #GameofThrones, as well as the joy of reading. However, more importantly, we chatted about his company, technologies, vision and ambition, and a little military strategy and history. Enjoy! Written interview here
Subscribe to our premium version and support the show. Follow us: | |||
| Episode #59 | IG Live with Mateusz (Matthew) Pawlik on 3D Printing Medical Devices for Animals | 24 Oct 2021 | 00:44:20 | |
In this fun and insightful conversation with the co-founder and co-owner of Cabiomede (Instagram: @CabiomedeVet), I learned a lot more about Mateusz Pawlik, who is behind many of the incredible 3D printing veterinary products for both surgical plannings and for educational purposes. As a young entrepreneur, Mateusz shared with us his earlier failures right out of school, later, business pivots, and future outlook on healthcare 3D printing, not just for veterinary medicine but also for human medicine. We discussed many challenges facing the industry, in particular, how to encourage healthcare providers to adopt a new way of practice and thinking. Mateusz Pawlik, co-owner of Cabiomede Graduate of Biomedical Engineering at the Silesian University of Technology in Poland. He gained his experience working in international companies in the medical industry as a product engineer and continuous development manager. Co-owner of CABIOMEDE – company providing R&D services in medical engineering area and Pets Analytics – startup developing an innovative solution in the field of animal health monitoring. Operations Manager responsible for new products and technology development – presurgical models, custom made surgical guides and implants, polymeric and metal spine and joint implants for animals. Together with CABIOMEDE team developed more than 500 patient’s cases on a basis of Computed Tomography. His biggest project was related to create veterinary surgical workshop models – full canine and feline fractures database according to AOVet classification. Subscribe to our premium version and support the show. Follow us: | |||
| Episode #57 | Prof. Ali Khademhosseini - Academic Entrepreneur | 30 Sep 2021 | 00:33:16 | |
In this episode of The Lattice podcast, we had the opportunity to chat with professor Ali Khademhosseini about his career, starting when he was a chemical engineering graduate student to becoming a full professor at Harvard, bicoastal move to UCLA, three-time entrepreneur, becoming an Amazon Fellow, to finally becoming the founder and director of the Terasaki Institute, a new educational research center that also wants to build young companies. While Ali has been incredibly productive in academia, his career trajectory is clearly towards academic entrepreneurship, an exciting concept to many scientists, especially in light of the pandemic and the rise of companies like Moderna. Given his success, I dug a little deeper into his secret sauce to achieve success. Fortunately, Ali was willing to share it with everyone as well as his evolving view on what is meaningful success to him and what he envisions his next achievement milestone. Since I knew Ali from his many works on biomaterials and 3D printing, we also discussed his vision for the field.
https://www.linkedin.com/in/alikmit/ Ali Khademhosseini is currently the CEO and Founding Director at the Terasaki Institute for Biomedical Innovation. Previously, he was a Professor of Bioengineering, Chemical Engineering and Radiology at the University of California-Los Angeles (UCLA). He joined UCLA as the Levi Knight Chair in November 2017 from Harvard University where he was Professor at Harvard Medical School (HMS) and faculty at the Harvard-MIT’s Division of Health Sciences and Technology (HST), Brigham and Women’s Hospital (BWH) and as well as associate faculty at the Wyss Institute for Biologically Inspired Engineering. At Harvard University, he directed the Biomaterials Innovation Research Center (BIRC) a leading initiative in making engineered biomedical materials. Dr. Khademhosseini is an Associate Editor for ACS Nano. He served as the Research Highlights editor for Lab on a Chip. He is a fellow of the American Institute of Medical and Biological Engineering (AIMBE), Biomedical Engineering Society (BMES), Royal Society of Chemistry (RSC), Biomaterials Science and Engineering (FBSE), Materials Research Society (MRS), NANOSMAT Society, and American Association for the Advancement of Science (AAAS). He is also the recipient of the Mustafa Prize ($500,000 prize) and is a member of the International Academy of Medical and Biological Engineering, Royal Society of Canada and Canadian Academy of Engineering, and National Academy of Inventors. He is an author on >650 peer-reviewed journal articles, editorials and review papers, >70 book chapters/edited books and >40 patents/patent applications. He has been cited >74,000 times and has an H-index of 139. He has made seminal contributions to modifying hydrogels and developing novel biomaterial solutions for addressing pressing problems in healthcare. He has founded 2 companies, Obsidio Medical and Bioray. He received his Ph.D. in bioengineering from MIT (2005), and MASc (2001) and BASc (1999) degrees from University of Toronto both in chemical engineering. Subscribe to our premium version and support the show. Follow us: | |||
| Episode #33 | Fireside Chat with Tamer Mohamed (Aspect Biosystems) and Mike Graffeo (Fluidform) | 10 Jun 2020 | 00:28:52 | |
A fun but insightful conversation during 3DHEALS2020 with two inspiring entrepreneurs in 3D Bioprinting space, Tamer Mohamed (CEO and co-founder of Aspect Biosystems), and Mike Graffeo (CEO and co-founder of Fluidform). Aspect bio has just successfully completed its series A round, and Fluidform just successfully raised its seed round. Learn from Tamer and Mike on what startup CEOs' challenges, experiences, visions, and advice for the biofabrication and 3D printing space. Subscribe to our premium version and support the show. Follow us: | |||
| Episode #31 | Orthopedic Surgery in the Era of Industry 4.0 - An Interview with Carlsmed CEO Mike Cordonnier | 24 May 2020 | 00:18:23 | |
Have a complex spine problem? Mike Cordonnier from Carlsmed may have an answer for you. While orthopedic surgeons are no strangers to virtual pre-operative surgical planning, it is a different challenge to also provide a patient-specific implant to fit into the patient, rather than molding patient to fit the device. In this interview with our upcoming 3DHEALS2020 speaker, Mike and I discussed how his company aims to realize medical imaging to patient-specific surgical plan and device, leveraging AI, cloud computing, data, and additive manufacturing (or 3D printing). We also touched upon how the ongoing COVID19 pandemic will change the future of surgery.
Subscribe to our premium version and support the show. Follow us: | |||
| Episode #28 | Interview with Dr. Shafkat Anwar, Pediatric Cardiologist & Director of Center of 3D Technologies, UCSF | 14 May 2020 | 00:19:02 | |
A lot of us started our journey in healthcare 3D printing accidentally. Listen to this ice-breaker style interview with Dr. Shafkat Anwar, Pediatric Cardiology Director of Cardiac MRI, as well as Co-Founder and Co-Director of the UCSF Center for Advanced 3D+ Technologies (CA3D+). Hear his story on how 3D+ Technologies beyond 3D printing is helping patients (and their families) fighting against congenital heart disease and how UCSF 3D+ Lab is combating against the ongoing pandemic. His full written interview can be found here. He will be speaking at "Point of Care" panel at the upcoming 3DHEALS2020 in June, 2020. He is the Pediatric Cardiology Director of Cardiac MRI, as well as Co-Founder and Co-Director of the UCSF Center for Advanced 3D+ Technologies (CA3D+). He is a founding member and the inaugural Chair of the Advanced 3D+ Visualization Special Interest Group in the Society for Cardiovascular Magnetic Resonance. He is a consultant at Printerprezz, a medical start-up in Fremont, CA utilizing additive and other advanced manufacturing technologies to develop the next generation of medical devices. At Printerprezz. Dr. Anwar serves as the Senior Vice President of Medical Innovations. Dr. Anwar completed his internship and residency in Pediatrics at Children’s National Medical Center, as well as a research fellowship at the National Institutes of Health. He completed fellowships in Pediatric Cardiology and Cardiac Imaging at Cleveland Clinic and Children’s Hospital of Philadelphia. Prior to joining UCSF, Dr. Anwar was the Cardiology Director of Cardiac MRI at Washington University in St. Louis, St. Louis Children’s Hospital. At Wash. U. Dr. Anwar co-founded and co-directed the Center for 3D Printing, a multi-disciplinary 3D printing center. He will be speaking at "Point of Care" panel at the upcoming 3DHEALS2020 in June, 2020. Subscribe to our premium version and support the show. Follow us: | |||
| Episode #16 | Interview with 3DHEALS2020 Speaker, Kevin Caldwell, CEO of Ossium Health | 28 Apr 2020 | 00:24:04 | |
Join me for a fascinating conversation with 3DHEALS2020 speaker, Kevin Caldwell, CEO and co-founder of Ossium Health, a startup building a bone marrow bank, and providing solutions to more available bone marrow transplant and other related cell therapies. Learn more about Kevin's personal journey as an entrepreneur, how such a bone marrow/stem cell band from organ donors can help biofabrication and tissue engineering, and the bioethical concerns with cell therapy and tissue engineering. The video version of this interview can be found here. Stay tuned for more in-depth written interview with Kevin at 3DHEALS.com. Subscribe to our premium version and support the show. Follow us: | |||